Carbamazepine and DOAC — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Carbamazepine may reduce apixaban exposure and anticoagulant effect
Carbamazepine is a strong enzyme inducer and can reduce exposure to some DOACs, risking treatment failure. This is particularly important in stroke prevention for AF. The pharmacist should contact the prescriber to consider an alternative anticoagulation strategy.
Reference: BNF